{"id":84777,"date":"2026-05-13T16:42:59","date_gmt":"2026-05-13T16:42:59","guid":{"rendered":"https:\/\/www.cofb.org\/?p=84777"},"modified":"2026-05-14T17:03:43","modified_gmt":"2026-05-14T17:03:43","slug":"farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/","title":{"rendered":"Farmac\u00e9uticos de hospital se actualizan en colangiocarcinoma"},"content":{"rendered":"

El pasado 22 de abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) <\/strong>organiz\u00f3 la formaci\u00f3n "Actualizaci\u00f3n en colangiocarcinoma"<\/strong>, con la colaboraci\u00f3n de Servier<\/a>. La sesi\u00f3n corri\u00f3 a cargo de David Conde<\/strong>, farmac\u00e9utico hospitalario en el Hospital Vall d'Hebron y vocal de Hospitales del COFB, y de Teresa Macarulla<\/strong>, onc\u00f3loga y jefe del Servicio de Oncolog\u00eda M\u00e9dica del Hospital Cl\u00ednic de Barcelona.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Los objetivos<\/strong> de la formaci\u00f3n fueron analizar la situaci\u00f3n actual de financiaci\u00f3n y posicionamiento de los tratamientos para el colangiocarcinoma<\/strong> y las condiciones de acceso<\/strong>, conocer los principales resultados de los estudios <\/strong>y las terapias dirigidas<\/strong> aplicadas al colangiocarcinoma y revisar los aspectos de seguridad y manejo farmacoterap\u00e9utico<\/strong> para optimizar el uso de estos tratamientos en el \u00e1mbito hospitalario.<\/p>\n\n\n\n

El vocal de Hospitales, durante su intervenci\u00f3n, abord\u00f3 la situaci\u00f3n actual de acceso a terapias dirigidas<\/strong> a nivel nacional. Para iniciar su ponencia comparti\u00f3 los aspectos clave de esta patolog\u00eda, que representa el 1% de todos los c\u00e1nceres<\/strong>, pero entre el 10% y el 15% de los c\u00e1nceres hep\u00e1ticos<\/strong> y se suele detectar en fases tard\u00edas<\/strong> debido a su naturaleza silenciosa y su localizaci\u00f3n compleja. "La ausencia de s\u00edntomas iniciales provoca que el diagn\u00f3stico se realice en fases tard\u00edas, pero en los \u00faltimos a\u00f1os ha habido un cambio de paradigma"<\/strong>, explic\u00f3. Seg\u00fan apunt\u00f3, de acuerdo con las recomendaciones de la European Society For Medical Oncology (ESMO), el uso de la secuenciaci\u00f3n de nueva generaci\u00f3n (NGS) es ahora una herramienta fundamental<\/strong> para determinar el manejo cl\u00ednico de los pacientes.<\/p>\n\n\n\n

\"\"<\/a>
David Conde durante su exposici\u00f3n. <\/figcaption><\/figure>\n\n\n\n

Durante su intervenci\u00f3n, repas\u00f3 los distintos tratamientos disponibles<\/strong> y especific\u00f3 que el 40% de los pacientes presentan alteraciones gen\u00f3micas accionables. En este sentido, dijo que el uso de secuenciaci\u00f3n masiva (NGS)<\/strong> deber\u00eda ser imprescindible al inicio del tratamiento sist\u00e9mico para identificar dianas terap\u00e9uticas espec\u00edficas.<\/p>\n\n\n\n

A continuaci\u00f3n, intervino la Dra. <\/strong>Macarulla <\/strong>que comparti\u00f3 con los asistentes los principales resultados de las distintas terapias dirigidas. Para ello, hizo referencia a diferentes estudios, datos de \u00e9stos en la vida real y la seguridad y manejo de las terapias dirigidas.<\/p>\n\n\n\n

\"\"<\/a>
La Dra. Macarulla en un momento de su intervenci\u00f3n. <\/figcaption><\/figure>\n\n\n\n

Durante la sesi\u00f3n, la doctora tambi\u00e9n analiz\u00f3 las necesidades compartidas por pacientes y onc\u00f3logos para afrontar esta enfermedad. En ese o\u00eddo, concluy\u00f3 que el diagn\u00f3stico precoz<\/strong> es el elemento clave para poder optar a tratamientos radicales. Asimismo, la Dra. Macarulla coincidieron en que es determinante disponer de la informaci\u00f3n gen\u00f3mica<\/strong> detallada desde el mismo momento del diagn\u00f3stico. En \u00faltima instancia, incidi\u00f3 en que es necesario continuar buscando mejores opciones de tratamiento que permitan aumentar la supervivencia global (SG)<\/strong> de los pacientes con colangiocarcinoma.<\/p>\n\n\n\n

Con la colaboraci\u00f3n de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

El pasado 22 de abril, el Colegio de Farmac\u00e9uticos de Barcelona (COFB) organiz\u00f3 la formaci\u00f3n "Actualizaci\u00f3n en colangiocarcinoma", con la colaboraci\u00f3n de Servier. La sesi\u00f3n corri\u00f3 a cargo de David Conde, farmac\u00e9utico hospitalario en el Hospital Vall d'Hebron y vocal de Hospitales del COFB, y de Teresa Macarulla, onc\u00f3loga [\u2026]<\/p>","protected":false},"author":3,"featured_media":84790,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[18,19,5534,53,2965,70,5535,5536],"class_list":["post-84777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-colangiocarcinoma","tag-farmaceutics","tag-farmaceutics-dhospitals","tag-formacio","tag-maneig-farmacoterapeutic","tag-terapies-dirigides"],"yoast_head":"\nFarmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-13T16:42:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-14T17:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma\",\"datePublished\":\"2026-05-13T16:42:59+00:00\",\"dateModified\":\"2026-05-14T17:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\"},\"wordCount\":506,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg\",\"keywords\":[\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"colangiocarcinoma\",\"farmac\u00e8utics\",\"farmac\u00e8utics d'hospitals\",\"Formaci\u00f3\",\"maneig farmacoterap\u00e8utic\",\"ter\u00e0pies dirigides\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\",\"url\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\",\"name\":\"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg\",\"datePublished\":\"2026-05-13T16:42:59+00:00\",\"dateModified\":\"2026-05-14T17:03:43+00:00\",\"description\":\"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/","og_locale":"es_ES","og_type":"article","og_title":"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier.","og_url":"https:\/\/www.cofb.org\/es\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2026-05-13T16:42:59+00:00","article_modified_time":"2026-05-14T17:03:43+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Berta Mart\u00ednez","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma","datePublished":"2026-05-13T16:42:59+00:00","dateModified":"2026-05-14T17:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/"},"wordCount":506,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg","keywords":["COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","colangiocarcinoma","farmac\u00e8utics","farmac\u00e8utics d'hospitals","Formaci\u00f3","maneig farmacoterap\u00e8utic","ter\u00e0pies dirigides"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/","url":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/","name":"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg","datePublished":"2026-05-13T16:42:59+00:00","dateModified":"2026-05-14T17:03:43+00:00","description":"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier.","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2026\/05\/13\/farmaceutics-dhospital-sactualitzen-en-colangiocarcinoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Farmac\u00e8utics d\u2019hospital s\u2019actualitzen en colangiocarcinoma"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/05\/COFB_COLANGIOCARCINOMA_14052026_1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 22 d\u2019abril, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cActualitzaci\u00f3 en colangiocarcinoma\u201d, amb la col\u00b7laboraci\u00f3 de Servier. La sessi\u00f3 va anar a c\u00e0rrec de David Conde, farmac\u00e8utic hospitalari a l\u2019Hospital de la Vall d\u2019Hebron i vocal d\u2019Hospitals del COFB, i de Teresa Macarulla, onc\u00f2loga […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/84777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=84777"}],"version-history":[{"count":8,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/84777\/revisions"}],"predecessor-version":[{"id":84797,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/84777\/revisions\/84797"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/84790"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=84777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=84777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=84777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}